The Whittingham Cancer Center / Norwalk Hospital — Norwalk, Connecticut

The Whittingham Cancer Center / Norwalk Hospital is a clinical research site located in Norwalk, Connecticut, United States 06856.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

The Whittingham Cancer Center / Norwalk Hospital has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Neoplasms, Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma.

Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Whittingham Cancer Center / Norwalk Hospital?

The Whittingham Cancer Center / Norwalk Hospital has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Whittingham Cancer Center / Norwalk Hospital conducted?

The Whittingham Cancer Center / Norwalk Hospital has 3 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Neoplasms, Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma.

Is The Whittingham Cancer Center / Norwalk Hospital accredited by Crixeo Health?

The Whittingham Cancer Center / Norwalk Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Whittingham Cancer Center / Norwalk Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.